Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino
I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado
{"title":"Impacto presupuestario de trabectedina y doxorubicina liposomal pegilada (DLP) para el tratamiento del cáncer de ovario parcialmente sensible al platino","authors":"I. Oyagüez, G. Cajaraville, J. M. D. Campo, M. Carreras, J. Montalar, J. M. Rubio, Beatriz García Andrés, M. Casado","doi":"10.1007/BF03320878","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03320878","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
